Key facts
- Notable investors include Hefei Industry Investment Group, Guoyao Venture Capital, Hefei Innovation Technology Venture Capital, USTC Silicon Valley.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Zhongke Ruiwo
- ·The full record, as it builds
Funding rounds
No funding rounds for Zhongke Ruiwo are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zhongke Ruiwo
Developer of cardiovascular covered stents designed for heart and vascular treatments. The company offers research, development, manufacturing, and sales of Class II and Class III medical devices, thereby providing innovative solutions for advanced cardiovascular care.
- Sector
- Healthcare
- HQ
- Hefei, China
- Founded
- 2022
- Employees
- 8
- Ownership
- Privately Held (backing)
Zhongke Ruiwo doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zhongke Ruiwo shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zhongke Ruiwo in its N-PORT filings yet. We sweep new filings monthly.